Pricing Log in Create free account

ANIXA BIOSCIENCES INC (ANIX) vs Humacyte, Inc. (HUMA)

ANIXA BIOSCIENCES INC and Humacyte, Inc. are both Biotechnology companies. ANIXA BIOSCIENCES INC and Humacyte, Inc. are of similar size ($109.9M and $105.3M). Humacyte, Inc. grew revenue faster over the last twelve months: 149.8% against −34.1%. ANIXA BIOSCIENCES INC has the higher net margin (0.00% vs −4,448.9%) and the higher return on invested capital (0.00% vs −433.7%). Across the 17 metrics below, ANIXA BIOSCIENCES INC leads on 11 and Humacyte, Inc. on 6.

Valuation

Metric ANIX HUMA Biotechnology median
P/E n/m n/m 10.60
P/S 111.13 48.58 9.40
P/B 8.18 3.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 100.73 41.40 9.02
Earnings yield (10.13%) (111.36%) (32.88%)
Free cash flow yield (6.80%) (94.68%) (23.13%)

Profitability

Metric ANIX HUMA Biotechnology median
Gross margin 0.00% (494.58%) 68.51%
Operating margin 0.00% (5,240.78%) 0.00%
Net margin 0.00% (4,448.89%) 0.00%
Free cash flow margin 0.00% (4,599.72%) 0.00%
Return on equity (72.57%) (534.42%) (51.96%)
Return on assets (63.45%) (68.16%) (46.06%)
Return on invested capital 0.00% (433.66%) 0.00%

Growth

Metric ANIX HUMA Biotechnology median
Revenue growth (TTM) (34.10%) 149.82% 6.76%
EPS growth (last fiscal year) 12.82% 79.37% 29.88%
Revenue growth, 5-year CAGR (6.89%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX HUMA Biotechnology median
Debt to equity 0.00 2.07 0.00
Current ratio 8.55 6.21 4.97
Net debt to EBITDA 1.29 (0.12) 1.01

Dividend

Metric ANIX HUMA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANIX HUMA Biotechnology median
Market cap 105.34m 109.87m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack